Vitamin Shoppe Beats on Both Top and Bottom Lines
Vitamin Shoppe (NYS: VSI) reported earnings on May 8. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Vitamin Shoppe beat expectations on revenues and beat expectations on earnings per share.
Compared with the prior-year quarter, revenue increased and GAAP earnings per share expanded significantly.
Margins improved across the board.
Vitamin Shoppe booked revenue of $248.1 million. The 12 analysts polled by S&P Capital IQ expected to see sales of $239.7 million on the same basis. GAAP reported sales were 14% higher than the prior-year quarter's $216.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.62. The 13 earnings estimates compiled by S&P Capital IQ predicted $0.57 per share. GAAP EPS of $0.61 for Q1 were 53% higher than the prior-year quarter's $0.40 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 35.6%, 90 basis points better than the prior-year quarter. Operating margin was 12.3%, 270 basis points better than the prior-year quarter. Net margin was 7.4%, 210 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $239.1 million. On the bottom line, the average EPS estimate is $0.49.
Next year's average estimate for revenue is $933.7 million. The average EPS estimate is $1.86.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 33 members out of 42 rating the stock outperform, and nine members rating it underperform. Among 20 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 12 give Vitamin Shoppe a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Vitamin Shoppe is outperform, with an average price target of $48.45.
Over the decades, small-cap stocks like Vitamin Shoppe have provided market-beating returns, provided they're value-priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Get instant access to this free report.
- Add Vitamin Shoppe to My Watchlist.
At the time this article was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings. He is the co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.